Shanghai, China · Founded 2018 · Privately Held (backing)
Developer and provider of drugs designed to treat cardiovascular and cerebrovascular diseases. CureGene Pharmaceutical is based in Shanghai, China and was founded in 2018. It has raised $27.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$27.8M
Last round
—
Team — not yet on record
No current team members for CureGene Pharmaceutical are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CureGene Pharmaceutical with a free account
·The complete investor list: 14 names
·Watch CureGene Pharmaceutical: the Monday email on marks, rounds and moves
